Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and Hematology-Oncologists who attended the event, either in person or virtually. The survey aimed to achieve two objectives: Identify the medical condition that participants considered to have the most exciting data presented Understand the aspects of the presented data that they found particularly exciting. Download the report ..read more

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb’s decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the depth of this impact on patients Identify prevalent challenges faced by them Understand potential changes in patients’ political engagement post the abortion policy shift. Employing a 3-minute microsurvey, we engaged 145 US-based healthcare professionals (Primary Care Physicians, Pediatricians, Emergency Medicine practitioners, an ..read more

In December of 2023, InCrowd surveyed 105 US attending Physicians and Residents to explore the possibility of implementing AI into Healthcare settings. As technological advancements continue to advance, we are noticing an increase in the conversation surrounding Artificial Intelligence (AI) in Healthcare settings. But how do HCPs feel about AI integration? InCrowd surveyed US attending Physicians and Residents to gauge their attitude regarding the emerging trend of AI being implemented into their practice.  When asked about familiarity with AI functionality, 100% of the respondents said t ..read more

What Doctors thought of this year’s ESMO Event Fielded in less than 7 days, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments they found most exciting. Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research. Learn what respondents thought of the latest advancements including NSCLC, breast cancer, and Urothelial cancer treatments. Download the report today. The p ..read more

Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise. In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR. Our 2023 report includes responses from over 100 qualified US-based healthcare professionals ..read more

Promotional Effectiveness Case Study Imagine how your promotional effectiveness tracking research would be enhanced with access to more than 750 unique oncologists/specialists each month. You’d collect higher quality responses (with tighter recruitment windows) from better respondents (targets, high decile). That’s how many unique oncologists/specialists InCrowd can deliver! A recent promo tracking study in multiple myeloma demonstrates InCrowd’s capability. Drawing from a pool of 755 unique oncologists who participated in September research, InCrowd pulled-in 435 of them to collect their expo ..read more

Charles is the VP of Digital Client Engagement & Strategic Growth for InCrowd. Learn more about him below! What is your role within InCrowd? My role at InCrowd is to ensure our technology is best positioned to provide value & insights to our key stakeholders. I’m lucky enough to introduce our tech to our research partners every week and experience their first-time joy along with them. It’s very rewarding & motivating. What interested you when deciding to join InCrowd? Easy one! The vision, people and energy. You work with our research partners, why do you think it is important for ..read more

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified US-based HCPs who have treated 20+ weight loss patients in the past month and prescribed prescription medications for weight loss. Unearth physician’s perspectives on: Top interventions for weight management patients The effectiveness of chronic weight management therapies Familiarity with chronic weight management treatments G ..read more

“Sadness is but a wall between two gardens.” —Kahlil Gibran As I noted in my last article, a self-assessment provides clarity for both your particular risks and unique solutions for burnout. Along with standard acts of nourishment, it is pivotal to align your values and use your strengths to recapture your inner vitality. My journey was long. Though I work in mental health (and unfortunately maybe even because of this) my self-assessment, insights, and interventions were hard-won. I did have one advantage, however, as I worked in the eating disorder field. I helped the most complex patients re ..read more

Mili is the SVP of Client Services at Survey Healthcare Global, the client research side of OpinionSite. Get to know more about her below! What do you love about working in the life science industry? I love that part of what we do impacts healthcare, with the ultimate goal to improve patient care. You work as the SVP of Client Services at Survey Healthcare Global, what’s the best part of your job? The best part of my job is the people I work with. We have an amazing group of people at this company, and I feel so fortunate to work together with them to share ideas, collaborate and ultimately en ..read more